Skip to content

How can India’s pharma companies survive under Trump’s uncertainty?

Finshots Daily

7m
Transcript

Original podcast

Where to listen

About this episode

In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.

Transcript

0:00
7:37

1,201 words · 1 speaker

Page updated · transcript and summary are machine-generated